Alto Neuroscience, Inc. (ANRO) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -27.09M | -11.52M | -9.92M | -13.78M | -16.56M | -13.02M | -11.73M | -11.69M | -10.98M | -11.52M | -7.76M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -63.63% | 11.56% | 15.42% | -17.83% | -50.74% | -12.99% | -51.01% | - | - | - | - |
| Net Income | -26.24M | -16.18M | -14.18M | -17.71M | -15.17M | -15.2M | -16.78M | -16.03M | -13.42M | -11.22M | -9.14M |
| Depreciation & Amortization | 184K | 157K | 164K | 169K | 171K | 170K | 135K | 113K | 97K | 92K | 63K |
| Stock-Based Compensation | 0 | 0 | 2.19M | 2M | 1.97M | 1.57M | 2M | 1.89M | 2.18M | 606K | 541K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 3.35M | 2.41M | 613K | 458K | 1.13M | 345K | 138K | 905K | 413K | 151K | -62K |
| Working Capital Changes | -4.39M | 2.1M | 1.3M | 1.29M | -4.66M | 99K | 2.79M | 1.43M | -255K | -1.16M | 834K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8K | 0 | 295K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.49M | -297K | 461K | 323K | -266K | -762K | 409K | -251K | 1.12M | -781K | -641K |
| Cash from Investing | -556K | 0 | 0 | 0 | -24K | -506K | -1M | -340K | -224K | -352K | -43K |
| Capital Expenditures | -556K | 0 | 0 | 0 | -24K | -506K | -1M | -340K | -224K | -352K | -43K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 114.94M | 50.19M | 153K | 613K | 9.13M | 49K | 1.32M | -234K | 134.56M | 43.13M | 49K |
| Debt Issued (Net) | 0 | 0 | 0 | 750K | 9.47M | 0 | 1.25M | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 115.13M | 50.19M | 153K | -556K | 198K | 0 | 67K | 0 | 137.58M | 45.03M | -60K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | -167K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -190K | 0 | 0 | 419K | -546K | 49K | 0 | -234K | -3.02M | -1.9M | 109K |
| Net Change in Cash | 87.28M | 38.67M | -9.77M | -13.17M | -7.47M | -13.47M | -11.42M | -12.27M | 123.35M | 31.26M | -7.74M |
| Free Cash Flow | -27.65M | -11.52M | -9.92M | -13.78M | -16.58M | -13.53M | -12.73M | -12.03M | -11.21M | -11.88M | -7.81M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -66.75% | 14.87% | 22.1% | -14.5% | -47.94% | -13.9% | -63.05% | - | - | - | - |
| FCF per Share | -0.84 | -0.36 | -0.37 | -0.51 | -0.61 | -0.50 | -0.47 | -0.45 | -0.42 | -0.44 | -0.29 |
| FCF Conversion (FCF/Net Income) | 1.03x | 0.71x | 0.70x | 0.78x | 1.09x | 0.86x | 0.70x | 0.73x | 0.82x | 1.03x | 0.85x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 248K | 0 | 251K | 248K | 0 | 246K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |